ImmunoGen, Inc. (IMGN) Social Stream
IMMUNOGEN INC (IMGN) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering IMMUNOGEN INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 7 | $12 | $5 | $7.9 | $29.7 | -73.4% |
| 2021-12-01 | 7 | $12 | $5 | $8.9 | $29.7 | -70.03% |
| 2022-02-02 | 7 | $12 | $6.5 | $9.3 | $29.7 | -68.69% |
| 2022-02-11 | 8 | $18 | $6.5 | $10.75 | $29.7 | -63.8% |
| 2022-03-09 | 8 | $18 | $5 | $10.416 | $29.7 | -64.93% |
| 2022-03-20 | 9 | $18 | $5 | $10.416 | $29.7 | -64.93% |
| 2022-03-21 | 9 | $18 | $5 | $9.642 | $29.7 | -67.54% |
| 2022-05-06 | 9 | $18 | $5 | $9.571 | $29.7 | -67.77% |
| 2022-08-01 | 9 | $18 | $4 | $9.666 | $29.7 | -67.45% |
| 2022-08-10 | 9 | $18 | $4 | $9.428 | $29.7 | -68.26% |
| 2022-08-31 | 9 | $18 | $4 | $9.285 | $29.7 | -68.74% |
| 2022-09-09 | 9 | $18 | $4 | $9.125 | $29.7 | -69.28% |
| 2022-11-07 | 10 | $18 | $4 | $9.125 | $29.7 | -69.28% |
| 2022-11-15 | 11 | $18 | $4 | $9.375 | $29.7 | -68.43% |
| 2022-11-16 | 11 | $20 | $4 | $11 | $29.7 | -62.96% |
| 2022-11-28 | 12 | $20 | $4 | $10.9 | $29.7 | -63.3% |
| 2023-01-05 | 12 | $19.001 | $4 | $10.4 | $29.7 | -64.98% |
| 2023-02-27 | 12 | $19.001 | $4 | $10.5 | $29.7 | -64.65% |
| 2023-03-02 | 12 | $19.001 | $3 | $10.4 | $29.7 | -64.98% |
| 2023-04-28 | 11 | $19.001 | $3 | $10.889 | $29.7 | -63.34% |
| 2023-05-01 | 11 | $19.001 | $3 | $11 | $29.7 | -62.96% |
| 2023-05-03 | 11 | $19.001 | $5 | $13.222 | $29.7 | -55.48% |
| 2023-05-09 | 11 | $19.001 | $8 | $13.555 | $29.7 | -54.36% |
| 2023-06-05 | 11 | $19.001 | $8 | $13.889 | $29.7 | -53.24% |
| 2023-06-06 | 11 | $19.001 | $8 | $14.333 | $29.7 | -51.74% |
| 2023-06-13 | 11 | $21 | $8 | $16.222 | $29.7 | -45.38% |
| 2023-06-16 | 11 | $24 | $8 | $17.111 | $29.7 | -42.39% |
| 2023-07-18 | 11 | $24 | $8 | $18 | $29.7 | -39.39% |
| 2023-07-27 | 11 | $24 | $8 | $18.444 | $29.7 | -37.9% |
| 2023-08-01 | 11 | $24 | $8 | $19 | $29.7 | -36.03% |
| 2023-08-02 | 11 | $27 | $9.001 | $22 | $29.7 | -25.93% |
| 2023-08-29 | 11 | $27 | $9.001 | $22.111 | $29.7 | -25.55% |
| 2023-09-13 | 11 | $27 | $13 | $23.555 | $29.7 | -20.69% |
| 2023-10-06 | 12 | $27 | $13 | $22.8 | $29.7 | -23.23% |
| 2023-11-02 | 12 | $27 | $13 | $22.9 | $29.7 | -22.9% |
| 2023-11-04 | 12 | $28 | $14 | $23.1 | $29.7 | -22.22% |
| 2023-11-29 | 13 | $28 | $14 | $23.272 | $29.7 | -21.64% |
| 2023-12-01 | 12 | $31 | $16 | $25.818 | $29.7 | -13.07% |
| 2023-12-04 | 12 | $31.26 | $22 | $28.426 | $29.7 | -4.29% |
| 2023-12-05 | 11 | $31.26 | $22 | $29.126 | $29.7 | -1.93% |
| 2023-12-20 | 12 | $31.26 | $17 | $28.387 | $29.7 | -4.42% |
| 2023-12-29 | 13 | $31.26 | $17 | $28.605 | $29.7 | -3.69% |
The Trend in the Analyst Price Target
IMGN's average price target has moved up $19.18 over the prior 17 months.
Over the past 49 weeks, IMGN's average upside potential has been 40.81%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-03 | 11 | 19.001 | 5 | 13.222 | 12.26 | 7.85% |
| 2023-06-16 | 11 | 24.000 | 8 | 17.111 | 18.44 | -7.21% |
| 2023-09-13 | 11 | 27.000 | 13 | 23.555 | 15.88 | 48.33% |
| 2023-11-10 | 13 | 28.000 | 14 | 23.272 | 14.76 | 57.67% |
| 2023-12-19 | 12 | 31.260 | 17 | 28.387 | 29.86 | -4.93% |
IMGN Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.85 | 1 | 0 | 12 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
IMGN's average broker recommendation rating worsened by 0.78 over the prior 45 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how IMMUNOGEN INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 184.76% of that group.
- In terms of how IMMUNOGEN INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -3789.65% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, IMMUNOGEN INC's average analyst price target is greater than 949.14% of them.
- In terms of how IMMUNOGEN INC fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 3500.07% of that group.
In the Pharmaceutical Products industry, HRTX, ADCT, and CERE are the three stocks most similar to IMMUNOGEN INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is IMGN a Buy, Hold or Sell? See the POWR Ratings now!